Overview of ongoing and completed studies

Relieve snoring with an app and exercises - available soon with more information

This nationwide scientific study aims to verify the effectiveness of digital therapy for treating severe obesity (Digital Health Application — DiGA) and to investigate the impact on the quality of life.

It is a certified medical device. The study is being carried out completely digitally throughout Germany. The study has been extended.

Multiple international prospective, randomised, and blinded trials, alongside a registry study, are evaluating whether a three-dimensional electrocardiogram with subsequent AI-powered analysis can determine an individual's risk of coronary ischaemia. The device in question is classified as a medical product.

The NHS is sponsoring a major field study in the United Kingdom. Participants are enrolled through their doctors, with subsequent monitoring conducted either in-person or via digital means, as clinically warranted.

This nationwide scientific study aims to test the effectiveness of a digital health application (DiGA) for quitting smoking. It is a medical device that provides scientifically based elements for quitting smoking.

The app contains elements that can increase motivation to stop smoking and make it easier to successfully deal with smoking cravings. The study is carried out completely digitally.

This multicenter, prospective, group-controlled study for early cancer detection is intended to verify whether a new blood test is suitable for distinguishing malignant tumours (cancers) from other tumories/diseases and control subjects.

The AFORCE-1 study aims to test the accuracy of this blood test before it can later be used in diagnostics. This includes patients with suspected tumours (10 most common types of tumours) and healthy volunteers. The development of suspected tumours is observed over a period of 12 months and compared with the results of the blood test for early cancer detection at the end of the study.

The study was rated positively on 05.04.2024 by the Colorectal Cancer Study Board of the German Cancer Society. It therefore meets the criteria for recognition of the study within the certification system and is included in studybox (www.studybox.de) listed. The registration number is: ST-U178.